Vai al contenuto principale della pagina
Titolo: | Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
Pubblicazione: | Washington, District of Columbia : , : National Academies Press, , [2012] |
©2012 | |
Descrizione fisica: | 1 online resource (132 p.) |
Disciplina: | 615.1/9 |
Soggetto topico: | Drug monitoring |
Drug development - United States | |
Drugs - United States - Design | |
Pharmaceutical industry - United States - Quality control | |
Soggetto genere / forma: | Electronic books. |
Persona (resp. second.): | OlsonSteve <1956-> |
ClaiborneAnne B. | |
Note generali: | Description based upon print version of record. |
Nota di bibliografia: | Includes bibliographical references (pages 71). |
Nota di contenuto: | Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN. |
Sommario/riassunto: | Advances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovative therapies and diagnostics. However, despite these opportunities, only a small fraction of investigational products are successfully developed into cures and therapies that can be accessed by patients. One response to the ever-widening gap between the number and promise of basic scientific discoveries and the translation of those discoveries into therapies is a renewed emphasis on collaborative approaches among federal agencies, academia, and industry, all directed at the advancement of the drug development enterprise. The newly developed Cures Acceleration Network (CAN)-a part of the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH)-has the potential to catalyze widespread changes in NCATS, NIH, and the drug development ecosystem in general. On June 4-5, 2012, the IOM Forum on Drug Discovery, Development, and Translation held, at the request of NCATS, a workshop-bringing together members of federal government agencies, the private sector, academia, and advocacy groups-to explore options and opportunities in the implementation of CAN. Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary summarizes the workshop."--Publisher's description. |
Titolo autorizzato: | Maximizing the impact of the Cures Acceleration Network |
ISBN: | 0-309-26117-1 |
Formato: | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione: | Inglese |
Record Nr.: | 9910463950903321 |
Lo trovi qui: | Univ. Federico II |
Opac: | Controlla la disponibilità qui |